人工角膜・角膜インプラントの世界市場2021年-2028年:種類別(ヒト角膜、人工角膜)、移植種類別、疾患兆候別、エンドユーザー別

◆英語タイトル:Artificial Cornea and Corneal Implant Market by Type (Human Cornea and Artificial Cornea), Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty, Anterior Lamellar Keratoplasty, and Keratoprosthesis), Disease Indication (Fuchs' Dystrophy, Fungal Keratitis, Keratoconus, and Others), and End User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics): Global Opportunity Analysis and Industry Forecast, 2021–2028
◆商品コード:AMR21JU062
◆発行会社(リサーチ会社):Allied Market Research
◆発行日:2021年5月27日
◆ページ数:215
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD6,168 ⇒換算¥678,480見積依頼/購入/質問フォーム
5 UserUSD6,929 ⇒換算¥762,190見積依頼/購入/質問フォーム
Enterprise UserUSD9,663 ⇒換算¥1,062,930見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAllied Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Allied Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査資料では、人工角膜・角膜インプラントの世界市場について調査し、イントロダクション、エグゼクティブサマリー、市場概要、種類別(ヒト角膜、人工角膜)分析、移植種類別(角膜移植、内皮角膜移植、前部層状角膜移植、ケラトプロテーゼ)分析、疾患兆候別(フックス角膜内皮変性症、真菌性角膜炎、円錐角膜、その他疾患)分析、エンドユーザー別(病院・外来手術センター、専門クリニック)分析、地域別分析、企業情報などを掲載しています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・人工角膜・角膜インプラントの世界市場規模:種類別(ヒト角膜、人工角膜)
・人工角膜・角膜インプラントの世界市場規模:移植種類別(角膜移植、内皮角膜移植、前部層状角膜移植、ケラトプロテーゼ)
・人工角膜・角膜インプラントの世界市場規模:疾患兆候別(フックス角膜内皮変性症、真菌性角膜炎、円錐角膜、その他疾患)
・人工角膜・角膜インプラントの世界市場規模:エンドユーザー別(病院・外来手術センター、専門クリニック)
・人工角膜・角膜インプラントの世界市場規模:地域別
・企業情報
【レポートの概要】

The global artificial cornea and corneal implant market generated $376.61 million in 2020 and is projected to reach $656.19 million by 2028, growing at a CAGR of 7.9% from 2021 to 2028.

A corneal transplant involves replacing a cloudy cornea with a clear donor cornea. Donor tissue comes from individuals who have donated their eyes for the benefit of others. The donor corneas used in transplants are kept freshly stored in eye banks. Furthermore, artificial cornea is an option for transplant patients who cannot tolerate a human donor cornea.

The global artificial cornea and corneal implant market is expected to witness a substantial growth in the future, driven by the rise in geriatric population and surge in prevalence of eye diseases. In addition, increase in prevalence of eye disorders and government initiatives to control visual impairment further boost the market growth. However, the high cost of ophthalmology devices and surgical procedures is expected to restrain the growth of the market during the forecast period.

Around 10 million people in world are reported to suffer from corneal blindness. Therefore, rise in incidences of corneal blindness is the primary factor that drives the growth of the artificial cornea implant market. Moreover, lack of availability of human cornea donor is responsible for the robust growth of the market. In addition, increase in incidences of trauma cases lead to high chances of eye injury, which further propel the market growth. The possibility of nerve regeneration after cornea transplant by human donor cornea is low while the possibility of nerve regeneration after biosynthetic cornea implant is high. The rejection of artificial cornea made up of alloplastic material by human eye is expected to be the major factor that restrains the growth of the market. Artificial cornea implant is a costly surgery, therefore the adoption for this surgery is quite low in the developing countries which deters the growth of the market during the forecast period. In addition, low availability of human cornea donor and high risk in the grafting artificial cornea implant have made a huge impact in the global market.

The artificial cornea and corneal implant market is segmented on the basis of type, transplant type, disease indication, end user, and region. By type, the market is divided into human cornea and artificial cornea. By transplant type, it is categorized into penetrating keratoplasty, endothelial keratoplasty, anterior lamellar keratoplasty and keratoprosthesis. By disease indication, the market is divided into Fuchs’ Dystrophy, Fungal Keratitis, Keratoconus and others. By end user, the market is segmented into hospitals, ambulatory surgical centers, and specialty clinics. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, UK, France, Spain, Italy, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The key players operating in the global artificial cornea and corneal implant market include AJL Ophthalmic, CorneaGen Inc., CorNeat Vision, LinkoCare Life Sciences AB, Presbia plc, Mediphacos, Aurolab, Cornea Biosciences, DIOPTEX GmbH, EyeYon Medical.

KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the artificial cornea and corneal implant market, and the current trends and future estimations to elucidate the imminent investment pockets.
• It presents a quantitative analysis of the market from 2020 to 2028 to enable stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of the key segments of the industry helps to understand the trends in artificial cornea and corneal implant globally
• Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS
By Type
• Human Cornea
• Artificial Cornea

By Transplant Type
• Penetrating Keratoplasty
• Endothelial Keratoplasty
• Anterior lamellar keratoplasty
• keratoprosthesis

By Disease Indication
• Fuchs’ Dystrophy
• Fungal Keratitis
• Keratoconus
• Others

By End User
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

By Region
North America
• U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific
• Japan
• China
• India
• Australia
• Rest of Asia-Pacific
LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT
• AJL Ophthalmic
• CorneaGen Inc.
• CorNeat Vision
• LinkoCare Life Sciences AB
• Presbia plc
• Mediphacos
• Aurolab
• Cornea Biosciences
• DIOPTEX GmbH
• EyeYon Medical

【レポートの目次】

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key Findings of the Study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Rise in prevalence of eye diseases across the globe
3.4.1.2.Surge in government initiatives to control visual impairment
3.4.1.3.Growth in geriatric population

3.4.2.Restraints

3.4.2.1.High cost of ophthalmology devices and surgical procedures
3.4.2.2.Low accessibility to eye care in low income countries

3.4.3.Opportunity

3.4.3.1.Shortage of corneal donors

3.5.COVID-19 impact on the artificial cornea and corneal implant market

CHAPTER 4:ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Human Cornea

4.2.1.Key market trends and growth opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country

4.3.Artificial Cornea

4.3.1.Key market trends and growth opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

CHAPTER 5:ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE

5.1.Overview

5.1.1.Market size and forecast

5.2.Penetrating Keratoplasty

5.2.1.Market size and forecast
5.2.2.Market analysis, by country

5.3.Endothelial Keratoplasty

5.3.1.Market size and forecast
5.3.2.Market analysis, by country

5.4.Anterior lamellar keratoplasty

5.4.1.Market size and forecast
5.4.2.Market analysis, by country

5.5.keratoprosthesis

5.5.1.Market size and forecast
5.5.2.Market analysis, by country

CHAPTER 6:ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION

6.1.Overview

6.1.1.Market size and forecast

6.2.Fuchs’ Dystrophy

6.2.1.Market size and forecast
6.2.2.Market analysis, by country

6.3.FUNGAL KERATITIS

6.3.1.Market size and forecast
6.3.2.Market analysis, by country

6.4.Keratoconus

6.4.1.Market size and forecast
6.4.2.Market analysis, by country

6.5.Other Diseases

6.5.1.Market size and forecast
6.5.2.Market analysis, by country

CHAPTER 7:ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER

7.1.Overview

7.1.1.Market size and forecast

7.2.Hospitals & Ambulatory Surgical Centers

7.2.1.Market size and forecast
7.2.2.Market analysis, by country

7.3.Specialty Clinics

7.3.1.Market size and forecast
7.3.2.Market analysis, by country

CHAPTER 8:ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY REGION

8.1.Overview

8.1.1.Market size and forecast

8.2.North America

8.2.1.Key market trends and opportunities
8.2.2.Market size and forecast, by country
8.2.3.North America artificial cornea and corneal implant market by Type
8.2.4.North America artificial cornea and corneal implant market by Transplant Type
8.2.5.North America artificial cornea and corneal implant market by Disease Indication
8.2.6.North America artificial cornea and corneal implant market by end user

8.2.6.1.U.S.

8.2.6.1.1.U.S. artificial cornea and corneal implant market by Type
8.2.6.1.2.U.S. artificial cornea and corneal implant market by Transplant Type
8.2.6.1.3.U.S. artificial cornea and corneal implant market by Disease Indication
8.2.6.1.4.U.S. artificial cornea and corneal implant market by end user

8.2.6.2.Canada

8.2.6.2.1.Canada artificial cornea and corneal implant market by Type
8.2.6.2.2.Canada artificial cornea and corneal implant market by Transplant Type
8.2.6.2.3.Canada artificial cornea and corneal implant market by Disease Indication
8.2.6.2.4.Canada artificial cornea and corneal implant market by end user

8.2.6.3.Mexico

8.2.6.3.1.Mexico artificial cornea and corneal implant market by Type
8.2.6.3.2.Mexico artificial cornea and corneal implant market by Transplant Type
8.2.6.3.3.Mexico artificial cornea and corneal implant market by Disease Indication
8.2.6.3.4.Mexico artificial cornea and corneal implant market by end user

8.3.Europe

8.3.1.Key market trends and opportunities
8.3.2.Market size and forecast, by country
8.3.3.Europe artificial cornea and corneal implant market by Type
8.3.4.Europe artificial cornea and corneal implant market by Transplant Type
8.3.5.Europe artificial cornea and corneal implant market by Disease Indication
8.3.6.Europe artificial cornea and corneal implant market by end user

8.3.6.1.Germany

8.3.6.1.1.Germany artificial cornea and corneal implant market by Type
8.3.6.1.2.Germany artificial cornea and corneal implant market by Transplant Type
8.3.6.1.3.Germany artificial cornea and corneal implant market by Disease Indication
8.3.6.1.4.Germany artificial cornea and corneal implant market by end user

8.3.6.2.France

8.3.6.2.1.France artificial cornea and corneal implant market by Type
8.3.6.2.2.France artificial cornea and corneal implant market by Transplant Type
8.3.6.2.3.France artificial cornea and corneal implant market by Disease Indication
8.3.6.2.4.France artificial cornea and corneal implant market by end user

8.3.6.3.UK

8.3.6.3.1.UK artificial cornea and corneal implant market by Type
8.3.6.3.2.UK artificial cornea and corneal implant market by Transplant Type
8.3.6.3.3.UK artificial cornea and corneal implant market by Disease Indication
8.3.6.3.4.UK artificial cornea and corneal implant market by end user

8.3.6.4.Rest of Europe

8.3.6.4.1.Rest of Europe artificial cornea and corneal implant market by Type
8.3.6.4.2.Rest of Europe artificial cornea and corneal implant market by Transplant Type
8.3.6.4.3.Rest of Europe artificial cornea and corneal implant market by Disease Indication
8.3.6.4.4.Rest of Europe artificial cornea and corneal implant market by end user

8.4.Asia-Pacific

8.4.1.Key market trends and opportunities
8.4.2.Market size and forecast, by country
8.4.3.Asia-Pacific artificial cornea and corneal implant market by Type
8.4.4.Asia-Pacific artificial cornea and corneal implant market, by Transplant Type
8.4.5.Asia-Pacific artificial cornea and corneal implant market, by Disease Indication
8.4.6.Asia-Pacific artificial cornea and corneal implant market by end user

8.4.6.1.Japan

8.4.6.1.1.Japan artificial cornea and corneal implant market by Type
8.4.6.1.2.Japan artificial cornea and corneal implant market by Transplant Type
8.4.6.1.3.Japan artificial cornea and corneal implant market by Disease Indication
8.4.6.1.4.Japan artificial cornea and corneal implant market by end user

8.4.6.2.China

8.4.6.2.1.China artificial cornea and corneal implant market by Type
8.4.6.2.2.China artificial cornea and corneal implant market by Transplant Type
8.4.6.2.3.China artificial cornea and corneal implant market by Disease Indication
8.4.6.2.4.China artificial cornea and corneal implant market by end user

8.4.6.3.Australia

8.4.6.3.1.Australia artificial cornea and corneal implant market by Type
8.4.6.3.2.Australia artificial cornea and corneal implant market by Transplant Type
8.4.6.3.3.Australia artificial cornea and corneal implant market by Disease Indication
8.4.6.3.4.Australia artificial cornea and corneal implant market by end user

8.4.6.4.India

8.4.6.4.1.India artificial cornea and corneal implant market by Type
8.4.6.4.2.India artificial cornea and corneal implant market by Transplant Type
8.4.6.4.3.India artificial cornea and corneal implant market by Disease Indication
8.4.6.4.4.India artificial cornea and corneal implant market by end user

8.4.6.5.Rest of Asia-Pacific

8.4.6.5.1.Rest of Asia-Pacific artificial cornea and corneal implant market by Type
8.4.6.5.2.Rest of Asia-Pacific artificial cornea and corneal implant market by Transplant Type
8.4.6.5.3.Rest of Asia-Pacific artificial cornea and corneal implant market by Disease Indication
8.4.6.5.4.Rest of Asia-Pacific artificial cornea and corneal implant market by end user

8.5.LAMEA

8.5.1.Key market trends and opportunities
8.5.2.Market size and forecast, by country
8.5.3.LAMEA artificial cornea and corneal implant market by Type
8.5.4.LAMEA artificial cornea and corneal implant market by Transplant Type
8.5.5.LAMEA artificial cornea and corneal implant market by Disease Indication
8.5.6.LAMEA artificial cornea and corneal implant market by end user

8.5.6.1.Brazil

8.5.6.1.1.Brazil artificial cornea and corneal implant market by Type
8.5.6.1.2.Brazil artificial cornea and corneal implant market by Transplant Type
8.5.6.1.3.Brazil artificial cornea and corneal implant market by Disease Indication
8.5.6.1.4.Brazil artificial cornea and corneal implant market by end user

8.5.6.2.Saudi Arabia

8.5.6.2.1.Saudi Arabia artificial cornea and corneal implant market, by Type
8.5.6.2.2.Saudi Arabia artificial cornea and corneal implant market, by Transplant Type
8.5.6.2.3.Saudi Arabia artificial cornea and corneal implant market, by Disease Indication
8.5.6.2.4.Saudi Arabia artificial cornea and corneal implant market, by end user

8.5.6.3.South Africa

8.5.6.3.1.South Africa artificial cornea and corneal implant market by Type
8.5.6.3.2.South Africa artificial cornea and corneal implant market, by Transplant Type
8.5.6.3.3.South Africa artificial cornea and corneal implant market, by Disease Indication
8.5.6.3.4.South Africa artificial cornea and corneal implant market, by end user

8.5.6.4.Rest of LAMEA

8.5.6.4.1.Rest of LAMEA artificial cornea and corneal implant market by Type
8.5.6.4.2.Rest of LAMEA artificial cornea and corneal implant market by Transplant Type
8.5.6.4.3.Rest of LAMEA artificial cornea and corneal implant market by Disease Indication
8.5.6.4.4.Rest of LAMEA artificial cornea and corneal implant market by end user

CHAPTER 9:COMPANY PROFILES

9.1.AJL Ophthalmic

9.1.1.Company overview
9.1.2.Company snapshot
9.1.4.Product portfolio

9.2.CorneaGen Inc

9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segment
9.2.4.Product portfolio
9.2.5.Key strategic moves and developments

9.3.CorNeat Vision

9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio

9.4.LinkoCare Life Sciences AB

9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio

9.5.Presbia plc

9.5.1.Company overview
9.5.2.Operating business segments
9.5.3.Product portfolio

9.6.Mediphacos

9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio

9.7.Aurolab

9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Business performance

9.8.Cornea Biosciences

9.8.1.Company snapshot
9.8.2.Operating business segments
9.8.3.Product portfolio

9.9.DIOPTEX GmbH

9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio

9.10.EyeYon Medical

9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio

LIST OF TABLES

TABLE 01.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 02.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR HUMAN CORNEA TYPE, BY REGION, 2020–2028 ($MILLION)
TABLE 03.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR ARTIFICIAL CORNEA TYPE, BY REGION, 2020–2028 ($MILLION)
TABLE 04.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020–2028 ($MILLION)
TABLE 05.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR PENETRATING KERATOPLASTY, BY REGION, 2020–2028 ($MILLION)
TABLE 06.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR ENDOTHELIAL KERATOPLASTY, BY REGION, 2020–2028 ($MILLION)
TABLE 07.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 08.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR FUCHS’ DYSTROPHY, BY REGION, 2020–2028 ($MILLION)
TABLE 09.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR FUNGAL KERATITIS, BY REGION, 2020–2028 ($MILLION)
TABLE 10.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR KERATOCONUS, BY REGION, 2020–2028 ($MILLION)
TABLE 11.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 12.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY REGION, 2020–2028 ($MILLION)
TABLE 13.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR SPECIALTY CLINICS, BY REGION, 2020–2028 ($MILLION)
TABLE 14.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR OTHERS, BY REGION, 2020–2028 ($MILLION)
TABLE 15.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 16.NORTH AMERICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 17.NORTH AMERICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 18.NORTH AMERICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 19.NORTH AMERICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 20.NORTH AMERICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 21.U.S. ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 22.U.S. ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 23.U.S. ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 24.U.S. ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 25.CANADA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 26.CANADA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 27.CANADA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 28.CANADA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 29.MEXICO ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 30.MEXICO ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 31.MEXICO ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 32.MEXICO ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 33.EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 34.EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 35.EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 36.EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 37.EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 38.GERMANY ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 39.GERMANY ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 40.GERMANY ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 41.GERMANY ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 42.FRANCE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 43.FRANCE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 44.FRANCE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 45.FRANCE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 46.UK ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 47.UK ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 48.UK ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 49.UK ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 50.REST OF EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 51.REST OF EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 52.REST OF EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 53.REST OF EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 54.ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 55.ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 56.ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 57.ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 58.ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 59.JAPAN ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 60.JAPAN ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 61.JAPAN ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 62.JAPAN ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 63.CHINA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 64.CHINA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 65.CHINA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 66.CHINA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 67.AUSTRALIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 68.AUSTRALIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 69.AUSTRALIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 70.AUSTRALIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 71.INDIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 72.INDIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 73.INDIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 74.INDIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 75.REST OF ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 76.REST OF ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 77.REST OF ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 78.REST OF ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 79.LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 80.LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 81.LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 82.LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 83.LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 84.BRAZIL ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 85.BRAZIL ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 86.BRAZIL ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 87.BRAZIL ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 88.SAUDI ARABIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 89.SAUDI ARABIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 90.SAUDI ARABIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 91.SAUDI ARABIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 92.SOUTH AFRICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 93.SOUTH AFRICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 94.SOUTH AFRICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 95.SOUTH AFRICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 96.REST OF LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 97.REST OF LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 98.REST OF LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 99.REST OF LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 100.AJL OPHTHALMIC: COMPANY SNAPSHOT
TABLE 101.AJL OPHTHALMIC: OPERATING SEGMENTS
TABLE 102.AJL OPHTHALMIC: PRODUCT PORTFOLIO
TABLE 103.CORNEAGEN INC: COMPANY SNAPSHOT
TABLE 104.CORNEAGEN INC: OPERATING SEGMENTS
TABLE 105.CORNEAGEN INC: PRODUCT PORTFOLIO
TABLE 106.CORNEAT VISION: COMPANY SNAPSHOT
TABLE 107.CORNEAT VISION : OPERATING SEGMENT
TABLE 108.CORNEAT VISION: PRODUCT PORTFOLIO
TABLE 109.LINKOCARE LIFE SCIENCES AB: COMPANY SNAPSHOT
TABLE 110.LINKOCARE LIFE SCIENCES AB: OPERATING SEGMENTS
TABLE 111.LINKOCARE LIFE SCIENCES AB: PRODUCT PORTFOLIO
TABLE 112.PRESBIA PLC: COMPANY SNAPSHOT
TABLE 113.PRESBIA PLC: OPERATING SEGMENTS
TABLE 114.PRESBIA PLC: PRODUCT PORTFOLIO
TABLE 115.MEDIPHACOS: COMPANY SNAPSHOT
TABLE 116.MEDIPHACOS: OPERATING SEGMENTS
TABLE 117.MEDIPHACOS: PRODUCT PORTFOLIO
TABLE 118.AUROLAB: COMPANY SNAPSHOT
TABLE 119.AUROLAB: OPERATING SEGMENTS
TABLE 120.AUROLAB: PRODUCT PORTFOLIO
TABLE 121.CORNEA BIOSCIENCES: COMPANY SNAPSHOT
TABLE 122.CORNEA BIOSCIENCES: OPERATING SEGMENTS
TABLE 123.CORNEA BIOSCIENCES: PRODUCT PORTFOLIO
TABLE 124.DIOPTEX GMBH: COMPANY SNAPSHOT
TABLE 125.DIOPTEX GMBH: OPERATING SEGMENTS
TABLE 126.DIOPTEX GMBH: PRODUCT PORTFOLIO
TABLE 127.EYEYON MEDICAL: COMPANY SNAPSHOT
TABLE 128.EYEYON MEDICAL: OPERATING SEGMENTS
TABLE 129.EYEYON MEDICAL: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET: SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.MODERATE BARGAINING POWER OF BUYERS
FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05.LOW THREAT OF NEW ENTRANTS
FIGURE 06.MODERATE THREAT OF SUBSTITUTION
FIGURE 07.MODERATE COMPETITIVE RIVALRY
FIGURE 08.MARKET DYNAMICS: ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET
FIGURE 09.PREVALENCE OF FUNGAL KERATITIS (CHRONIC BRONCHITIS AND EMPHYSEMA) AMONG AMERICANS, 2020
FIGURE 10.NUMBER OF PERSONS AGED 65 YEARS OR OVER BY GEOGRAPHIC REGION, 2020 AND 2050
FIGURE 11.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR HUMAN CORNEA TYPE, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 12.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR ARTIFICIAL CORNEA TYPE, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 13.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR PENETRATING KERATOPLASTY, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR ENDOTHELIAL KERATOPLASTY, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR FUCHS’ DYSTROPHY, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR FUNGAL KERATITIS, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR KERATOCONUS, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR OTHERS, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 21.HILL-ROM: NET SALES, 2018–2020 ($MILLION)
FIGURE 22.HILL-ROM: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 23.HILL-ROM: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 24.SMITHS MEDICAL: NET SALES, 2018–2020 ($MILLION)
FIGURE 25.SMITHS MEDICAL: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 26.SMITHS MEDICAL: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 27.TELEFLEX: NET SALES, 2018–2020 ($MILLION)
FIGURE 28.TELEFLEX: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 29.TELEFLEX: REVENUE SHARE, BY REGION, 2020 (%)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[人工角膜・角膜インプラントの世界市場2021年-2028年:種類別(ヒト角膜、人工角膜)、移植種類別、疾患兆候別、エンドユーザー別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆